Clinical Significance of Intestinal Fungal Overgrowth: Integrating the Gut Mycobiome into Modern Gastroenterology
Microorganisms · 19.06.2026 · 14 (6) · 1365
DOI: 10.3390/microorganisms14061365 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 19.06.2026. Verfasst von Jisoon Im und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Practice and Community Health, Ajou University School of Medicine, 164 World Cup-ro, Yeongtong-gu, Suwon 16499, Republic of Kore…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intestinal fungal overgrowth (IFO) is an increasingly recognized yet underexplored component of gut dysbiosis with potential implications for gastrointestinal and systemic disease. While bacterial microbiota have historically garnered research attention, recent advances in sequencing technologies have highlighted the importance of the gut mycobiome in maintaining intestinal homeostasis. Disruption of fungal–bacterial balance, particularly involving Candida albicans, C. tropicalis, and C. glabrata, may contribute to symptom generation through immune activation, epithelial barrier dysfunction, biofilm formation, and the production of toxic metabolites such as acetaldehyde and candidalysin. Emerging clinical evidence suggests that IFO is associated with persistent gastrointestinal symptoms, including bloating, abdominal discomfort, and altered bowel habits, particularly in patients who do not respond to conventional therapies targeting bacterial overgrowth. Furthermore, fungal dysbiosis involving Malassezia restricta and Saccharomyces cerevisiae has been associated with inflammatory bowel disease, metabolic disorders, and systemic immune dysregulation; however, the nature and directionality of these relationships remain incompletely understood. Despite increasing recognition, the diagnosis of IFO remains challenging due to a lack of standardized criteria and validated non-invasive tools. Therapeutic strategies, including antifungal agents such as fluconazole and nystatin, as well as microbiome-targeted interventions, show promise but require further validation. This review provides a comprehensive synthesis of current evidence regarding the epidemiology, pathophysiology, clinical manifestations, diagnostic challenges, and therapeutic implications of IFO, with particular emphasis on species-specific mechanisms. Recognition of the intestinal mycobiome as a potentially important component of gut health may provide new perspectives for understanding gastrointestinal disorders and inform future precision medicine approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Family Practice and Community Health, Ajou University School of Medicine, 164 World Cup-ro, Yeongtong-gu, Suwon 16499, Republic of Korea.
- Plastic Surgery, Cheongdamrui Plastic Surgery, Jeju 63083, Republic of Korea.
- GreenCross I-MED Gangnam Center, Majestar City Tower 1, 4F, 12 Seocho-daero 38-gil, Seocho-gu, Seoul 06655, Republic of Korea.
- Philip Medical Center, 10 Hwangsaeul-ro, 311 beon-gil, Bundang-gu, Seongnam-si 13590, Republic of Korea.
- Biochemistry & Molecular Medicine, GW Cancer Center, School of Medicine & Health Sciences, The George Washington University, Ross Hall 437C, Washington, DC 20037, USA.
ORCID-Profile: Kyucheol Lee, Sang-Hoon Lee, Kyu-Nam Kim, Jiyoung Lee
Zitieren
APA
Im, J., Lee, K., Lee, S. H., Jung, S., Kim, K. N., & Lee, J. (2026). Clinical Significance of Intestinal Fungal Overgrowth: Integrating the Gut Mycobiome into Modern Gastroenterology. Microorganisms, 14(6), 1365. https://doi.org/10.3390/microorganisms14061365
Vancouver
Im J, Lee K, Lee SH, Jung S, Kim KN, Lee J. Clinical Significance of Intestinal Fungal Overgrowth: Integrating the Gut Mycobiome into Modern Gastroenterology. Microorganisms. 2026;14(6):1365. doi:10.3390/microorganisms14061365
BibTeX
@article{Im2026,
author = {Im, Jisoon and Lee, Kyucheol and Lee, Sang-Hoon and Jung, Soohwan and Kim, Kyu-Nam and Lee, Jiyoung},
title = {Clinical Significance of Intestinal Fungal Overgrowth: Integrating the Gut Mycobiome into Modern Gastroenterology},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {6},
pages = {1365},
doi = {10.3390/microorganisms14061365}
}
EUVIMED